Literature DB >> 30717865

Management of Peanut Allergy.

Carina Venter1, Scott H Sicherer2, Matthew Greenhawt3.   

Abstract

Peanut allergy is a growing public health concern in westernized countries. Peanut allergy is characterized as an often severe and lifelong allergy, which can have detrimental effects on quality of life and trigger anxiety. Although multiple therapeutic options are emerging, the focus of current management strategies is strict peanut avoidance and carriage of self-injectable epinephrine. The greatest risk of reacting to peanut comes from direct ingestion, whereas casual skin contact or airborne exposure is highly unlikely to provoke significant symptoms. Patients and families must be educated about how to best execute strict peanut avoidance through careful label reading as well as how to understand and address likely and unlikely risk with regard to peanut exposure in public, in particular when dining outside of the home and for children attending school or child care. This review discusses the risk of exposure in public such as at school or on an airplane and how such risk can be abated, situations and scenarios when dining out of the house that may pose more risks than others, the essentials of US and EU label reading laws with particular emphasis on precautionary labeling and the risk implied by such, quality of life and psychosocial issues that may affect the peanut allergic individual and family, and a discussion of how risk may differ and evolve based on the patient's age.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergen avoidance; Anaphylaxis; Epinephrine; Epinephrine auto-injector; Food allergy; Food allergy labeling; Peanut allergy; Peanut allergy management; Quality of life

Mesh:

Year:  2019        PMID: 30717865     DOI: 10.1016/j.jaip.2018.10.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  5 in total

Review 1.  Food Allergy from Infancy Through Adulthood.

Authors:  Scott H Sicherer; Christopher M Warren; Christopher Dant; Ruchi S Gupta; Kari C Nadeau
Journal:  J Allergy Clin Immunol Pract       Date:  2020-06

2.  IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.

Authors:  Stephen C Dreskin; Matthew Germinaro; Dominik Reinhold; Xueni Chen; Brian P Vickery; Michael Kulis; A Wesley Burks; Surendra S Negi; Werner Braun; Jeffery M Chambliss; Spodra Eglite; Caitlin M G McNulty
Journal:  Pediatr Allergy Immunol       Date:  2019-10-21       Impact factor: 6.377

3.  Gut Microbial Signatures Associated with Peanut Allergy in a BALB/c Mouse Model.

Authors:  Shimin Gu; Qiang Xie; Chen Chen; Chenglong Liu; Wentong Xue
Journal:  Foods       Date:  2022-05-12

Review 4.  Early intervention of atopic dermatitis as a preventive strategy for progression of food allergy.

Authors:  Alyssa Sweeney; Vanitha Sampath; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2021-03-16       Impact factor: 3.406

Review 5.  Latest Developments in the Management of Nut Allergies.

Authors:  H A Brough; R Gourgey; S Radulovic; J C Caubet; G Lack; A Anagnostou
Journal:  Curr Treat Options Allergy       Date:  2021-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.